NCT07765095 Pericapsular Nerve Group (PENG) Block on Postoperative Pain Management After Acetabular Fracture Fixation
| NCT ID | NCT07765095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Puerto Rico |
| Condition | Acetabular Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2025-09-08 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2025-09-08 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to find out whether a Pericapsular Nerve Group (PENG) block, a type of nerve block used to control pain, can reduce pain after surgery in adults with an acetabular (hip socket) fracture who are undergoing surgical repair. The study will also evaluate the safety of the PENG block. The main questions this study aims to answer are: Does a PENG block reduce pain after surgery? Does a PENG block reduce the need for opioid pain medications after surgery? Are there any side effects or complications related to the PENG block? Researchers will compare patients who receive a PENG block with patients who do not receive a PENG block to determine whether the block improves pain control after surgery. Participants will: Be randomly assigned to receive either a PENG block or no PENG block before surgery while under general anesthesia. Undergo surgery to repair their acetabular fracture. Receive the same standard pain medications after surgery. Be asked to rate their pain at several time points after surgery using a standard pain scale. Have their use of pain medications, recovery, and any side effects recorded during their hospital stay and follow-up.
Eligibility Criteria
Inclusion Criteria: * Patient age 18 years or older * Acetabular Fracture amenable to surgery through the Kocher-Langenbeck approach * Full weight-bearing capacity prior to the trauma * Providing written informed consent Exclusion Criteria: * Age less than 18 years old * Fracture pattern not amenable to surgery through Kocher-Langenbeck approach * Lower extremity fracture ipsilateral to the acetabular fracture * Any traumatic injury that requires surgical management by other surgical specialty * Bilateral Acetabular Fractures * Limited weight bearing capacity prior to the trauma * Procedure performed under any anesthesia other than GETA * Chronic opioid use * History of Substance Abuse * Allergies or history of adverse reactions to any of the drugs used in the * Mental Disability * History of Psychiatric disorders
Contact & Investigator
Luis Lojo Sojo, MD
PRINCIPAL INVESTIGATOR
University of Puerto Rico
Frequently Asked Questions
Who can join the NCT07765095 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acetabular Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07765095 currently recruiting?
Yes, NCT07765095 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Puerto Rico to inquire about joining.
Where is the NCT07765095 trial being conducted?
This trial is being conducted at San Juan, Puerto Rico.
Who is sponsoring the NCT07765095 clinical trial?
NCT07765095 is sponsored by University of Puerto Rico. The principal investigator is Luis Lojo Sojo, MD at University of Puerto Rico. The trial plans to enroll 56 participants.